Roth MKM upgraded Cinemark to Buy from Neutral with a price target of $26, up from $19. The company should “prosper” over the next few years, driven by meaningful box office improvement, its debt reduction plans, and a likely reintroduction of capital returns, the analyst tells investors in a research note. The firm says that with the shares trading at less than six-times its estimated 2025 EBITDA with a 10% free cash flow yield, Cinemark’s valuation is very attractive. Roth is increasingly optimistic about upcoming box office releases, especially the big “mega-franchises” slated in 2025 and 2026.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CNK:
- Sony deal for Alamo Drafthouse boosts cinema names
- Cinemark management to meet with Barrington
- Cinemark Holdings (NYSE:CNK): Riding Out the Entertainment Industry Recession
- Netflix Stock (NASDAQ:NFLX): The Box Office Has No Answer to Streaming
- Cinemark price target raised to $16 from $14 at B. Riley